Danaher Stock News

These five companies have been investor favorites, but can they stay in favor this earnings season?

Griffon (GFF) completes the acquisition of Hunter Fan, now part of the CPP segment. The buyout is predicted to be immediately accretive to the company's earnings and cash flow.

ESG ETFs can help investors boost returns while supporting companies that make the world better.

These five companies have been investor favorites, but can they stay in favor this earnings season?

Stocks Analysis by Zacks Investment Research covering: 3M Company, ITT Inc, Danaher Corporation, Carlisle Companies Incorporated. Read Zacks Investment Research''s latest article on Investing.com

Crane's (CR) Q4 earnings reflect gains from solid segmental performance and improved margin. It projects higher revenues and earnings for 2022 and announces shareholder rewards with a dividend hike.

3M (MMM) delivered earnings and revenue surprises of 13.79% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Pune, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Global Pharmaceutical & Biotechnology Environmental Monitoring Market Analysis and Insights : The global Pharmaceutical & Biotechnology Environmental Monitoring market size is projected to reach USD 1326.4 million by 2027, from USD 888 million in 2020, at a CAGR of 5.9% during 2021-2027 . Global " Pharmaceutical & Biotechnology Environmental Monitoring Market " Research Report provides vital evaluation accessible status of the Pharmaceutical & Biotechnology Environmental Monitoring with finest statistical data points, qualified feelings, definition, meaning, SWOT examination, and the most recent developments worldwide. It also includes estimates based on an acceptable set of expectations and processes. The research takes into account the revenue generated by This Report''s sales as well as improvements made by various application segments. The assessment report examines and provides information based on advertise segments such as geologies, applications, and industries.

Conglomerate's Q4 results are likely to reflect gains from better economic and manufacturing activities, supply-chain woes, and cost inflation. Earnings releases by GE, DHR and MMM are worth a look.

Danaher (DHR) Q4 results to reflect gains from better-than-expected segmental top-line performances, mainly Diagnostics and Life Sciences. Cost inflation is likely to have been affecting margins.

Danaher (DHR) Q4 results to reflect gains from better-than-expected segmental top-line performances, mainly Diagnostics and Life Sciences. Cost inflation is likely to have been affecting margins.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

General Electric's (GE) 10-year partnership deal with Circle Health will likely improve patient health outcomes across the latter's network of around 50 hospitals in the United Kingdom.

Danaher (DHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co

Danaher (DHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co